A base‐promoted cyclisation of 4‐nitroso‐5‐benzylsulphonamidopyrazoles (VII) afforded 6 H ‐pyrazolo [ 3,4‐ c][ 1,2,5 ] thiadiazine‐2,2‐dioxides (VIII). They were tested in vitro for antifungal activity against a series of phytopathogenic fungi of different taxonomic classes. Five of the compounds had noteworthy activity; in particular 6 H ‐3‐phenyl‐5‐methyl‐7– ( 3,4‐dichlorophenyl) pyrazolo [ 3,4‐ c][ 1,2,5 ] thiadiazine‐2,2‐dioxide (VIIIc) at the concentration of 200 mg litre −1 completely inhibited the growth of Pythium ultimum, Corticium solani and Sclerotinia minor.
No takes yet. Share an insight, caveat, or question.
Vicentini et al. (1990) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: